基于FDA不良事件报告系统数据库的lorazepam的现实世界药监测研究
Chunyue Fang1,2, Xiaoyan Xu3, Jianyi Li4
1Department of Pharmacy, The Third People's Hospital of Yunnan Province, Kunming, 650011, Yunnan, China.
这项研究分析了现实世界的洛拉泽帕姆安全数据,确定了已知的不良事件和新的信号,如心动减速和肺炎. 研究结果揭示了洛拉泽帕姆的重要性别和年龄相关差异.
科学领域:
- 药物监督 药物监督 药物监督
- 临床安全 临床安全
- 现实世界的证据.
背景情况:
- 洛拉泽是广泛用于治疗焦虑和抑郁症的药物.
- 了解其现实世界的安全概况对于临床实践至关重要.
研究的目的:
- 用现实世界的数据来评估洛拉泽的安全性.
- 为了识别与洛拉泽帕姆使用相关的潜在的新不良事件 (AE) 信号.
主要方法:
- 利用了美国食品和药物管理局从2004年1月到2024年6月的不良事件报告系统 (FAERS) 的数据.
- 采用了四种信号量化算法:报告几率比率 (ROR),比例报告比率 (PRR),贝叶斯信任传播神经网络 (BCPNN) 和多项马鱼缩小器 (MGPS).
- 进行了性别分层和年龄分层分析,以探索AE的人口变化.
主要成果:
- 主要的AE类别包括精神疾病,神经系统疾病,受伤/中毒和心脏疾病.
- 确定了新的潜在的AE信号:高心力衰竭,腹肌溶解,新生病,发口恐惧症,胰腺纤维化和肺炎.
- 观察到的性别差异:女性中毒风险更高,男性镇静风险更高. 在AE中也注意到了年龄的变化.
结论:
- 该研究的结果与现有的临床试验数据对洛拉泽帕姆安全性一致.
- 发现了几种新的潜在不良事件信号,需要进一步调查.
- 在lorazepam的不良事件概况中显示出显著的性别和年龄相关差异,提供了有价值的临床见解.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Anxiolytic Drugs: Benzodiazepines and Buspirone
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
